Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Acquisitions & Divestments (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 8 years of Change in Acquisitions & Divestments data on record, last reported at $16.4 million in Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 119.7% year-over-year to $16.4 million; the TTM value through Dec 2025 reached $90.3 million, down 28.35%, while the annual FY2025 figure was $90.3 million, 28.35% down from the prior year.
  • Change in Acquisitions & Divestments reached $16.4 million in Q4 2025 per AMPH's latest filing, down from $22.5 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $65.8 million in Q2 2024 and bottomed at -$179000.0 in Q4 2023.
  • Average Change in Acquisitions & Divestments over 5 years is $15.1 million, with a median of $10.1 million recorded in 2022.
  • Peak YoY movement for Change in Acquisitions & Divestments: soared 18680.95% in 2021, then crashed 101.43% in 2023.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $1.3 million in 2021, then surged by 827.6% to $12.5 million in 2022, then plummeted by 101.43% to -$179000.0 in 2023, then surged by 4281.01% to $7.5 million in 2024, then skyrocketed by 119.7% to $16.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were $16.4 million in Q4 2025, $22.5 million in Q3 2025, and $23.0 million in Q2 2025.